Answers are grounded in this paper and cite their sources.
Lysosomes are multifunctional organelles that store and release calcium ions (Ca 2+ ), a key second messenger. Two-pore channels (TPCs) and members of the transient receptor potential (TRP) mucolipin (TRPML) subfamily are the principal lysosomal Ca 2+ release channels, but how Ca 2+ is taken up by lysosomes is less clear. TPCs have emerged as unusual ion channels that are able to dramatically switch their ion selectivity from a Ca 2+ -permeable state to a more Na + -selective state to differentially control cell-wide Ca 2+ signals and lysosomal function in an agonist-selective manner. Long-sought accessory proteins that confer sensitivity of these channels to the Ca 2+ mobilizing messenger nicotinic acid adenine dinucleotide phosphate (NAADP) have been identified as JPT2 and Lsm12. Functional roles for TPCs in trafficking both inwardly (phagocytosis) as well as outwardly (hormone/inflammatory mediator secretion and adhesion molecule presentation) have been resolved—roles likely linked to the actions of TPCs at membrane contact sites between the endolysosomal system and the endoplasmic reticulum (ER). Gain-of-function in TPC2 by mutation, or by loss of a negative channel regulation (through TMEM63A), causes pigmentation and pancreatic dysfunction, respectively. Inhibiting TPCs by molecular or chemical means, in particular with tetrandrine (for which analog-bound structures exist), is proving beneficial in models of Alzheimer disease, Parkinson's disease, stroke, and melanoma. Select activation of TPC2 by new “mode-switching” agonists appears to be equally beneficial in correcting lysosomal storage disorders and Parkinson's disease. Like TPCs, TRP mucolipins are activated by the phosphoinositide PI(3,5)P 2 . More recently discovered endogenous TRP mucolipin activators include pressure and PI(3)P. Also, like TPCs, TRP mucolipins appear functionally coupled to Ca 2+ channels on the sarcoplasmic reticulum with a surprising role for TRPML1 in generating ryanodine receptor-dependent subcellular Ca 2+ signals underpinning smooth muscle contractility. Insight into regulation of autophagy by TRP mucolipins accrues; we also now know that activation of TRPML1 results in direct Ca 2+ transfer from lysosomes to mitochondria at contact sites between the two organelles, and that this communication is disrupted in Mucolipidosis type IV, as well as in models of other neurogenerative diseases. TRP mucolipins are implicated in lung dysfunction and cancer, with the first identification of cancer-causing mutations in TRPML3. TRP mucolipin agonists have now been used successfully to correct phenotypes in a number of disease models, and agonist, as well as antagonist-bound structures, are providing new atomic insight into channel workings. The molecular basis for lysosomal Ca 2+ uptake continues to be actively investigated. Candidates include the Ca 2+ transporter TMEM165, the mutation of which is known to cause congenital disorders of glycosylation, and pumps such as ATP13A2 and those found typically on the ER.
No takes yet. Share an insight, caveat, or question.
Sandip Patel (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: